Ketorolac is available in multiple formulations, including injection, oral tablets, nasal spray, and ophthalmic drops. Pricing varies significantly depending on the form, dosage strength, manufacturer, pharmacy markup, and country. Injectable ketorolac is typically the most expensive due to sterile production and clinical‑grade use, while tablets are generally the most affordable option for short‑term outpatient therapy.
This page provides a complete overview of ketorolac pricing across all major forms to help you understand typical cost ranges before purchasing. For deeper pharmacological context, see the Ketorolac tromethamine page, and for brand‑specific pricing, visit the Toradol price guide. This is a pricing overview, not a medical recommendation.
Ketorolac pricing varies significantly depending on formulation, dosage strength, manufacturer, pharmacy markup, and country. Because ketorolac is available in multiple forms — including injection, oral tablets, nasal spray, and ophthalmic drops — each format has its own cost structure. Injectable ketorolac is typically the most expensive due to sterile production and clinical‑grade use, while tablets are generally the most affordable. Insurance coverage may reduce the cost, but this depends on region and provider.
The form of ketorolac has the strongest impact on price. IM/IV injections cost more because they require sterile manufacturing, specialized packaging, and hospital‑level distribution. Higher doses such as 30 mg and 60 mg are priced above 15 mg versions. Oral tablets (usually 10 mg) are cheaper due to simpler production and wider availability. Nasal spray and ophthalmic drops fall into the mid‑to‑high price range due to specialized delivery systems and smaller production volumes.
Ketorolac is the generic form of Toradol, making it significantly cheaper. Generic ketorolac does not carry brand‑level marketing or development costs and is produced by multiple manufacturers, increasing competition and lowering prices. Despite the lower cost, generic ketorolac contains the same active ingredient and must meet identical regulatory standards for quality and efficacy.
Ketorolac injection (IM/IV) is the most expensive form of the medication due to sterile manufacturing, clinical‑grade packaging, and hospital‑level distribution. It is available in several strengths, most commonly 15 mg, 30 mg, and 60 mg. Higher‑dose vials typically cost more because they contain more active ingredient and are used in more severe pain scenarios.
The 30 mg formulation is the most widely used and often priced higher than the 15 mg dose due to demand and clinical preference. More details are available on the Ketorolac 30 mg injection page. The 60 mg formulation is typically the most expensive per vial and is used in acute, high‑intensity pain settings. See the Ketorolac 60 mg injection page for specifics.
Ketorolac injections are commonly used in hospitals, surgical centers, and emergency departments, which contributes to higher pricing due to institutional procurement models. Retail pharmacies may also carry injectable ketorolac, but prices vary depending on region, insurance coverage, and pharmacy markup.
Overall, ketorolac injection is the costliest form of the medication, reflecting its potency, clinical utility, and manufacturing complexity.
Ketorolac tablets are typically the most affordable form of the medication. The standard dosage is 10 mg, and tablets are widely available in generic versions, making them highly cost‑effective. Pricing varies depending on package size, manufacturer, and pharmacy markup, but oral ketorolac consistently remains cheaper than injectable forms.
The cost per tablet is generally low because oral formulations require simpler production processes and do not involve sterile manufacturing. Generic ketorolac tablets offer the lowest price point, making them a practical option for short‑term outpatient therapy. More details are available on the Toradol tablets page.
Ketorolac tablets are often used as continuation therapy after an initial injection, which also contributes to their lower cost. They are widely stocked in retail pharmacies, making pricing more competitive compared with hospital‑only formulations.
Overall, ketorolac tablets provide the most economical way to access this medication for short‑term pain management.
Ketorolac nasal spray is a less common formulation and is typically priced higher than tablets due to its specialized delivery system. The nasal route allows rapid absorption without injection, making it useful for patients who require fast relief but prefer a non‑invasive option.
Because nasal sprays require advanced manufacturing technology and smaller production volumes, their price is generally higher than oral formulations. Availability may also vary by region, which can further influence cost. More details are available on the Toradol nasal spray page.
Ketorolac nasal spray is often used in outpatient settings or for patients who cannot take oral medications, contributing to its higher price point.
Ketorolac ophthalmic solutions, sold under names such as Acular, Acular LS, and Acuvail, are used for postoperative ocular pain and inflammation. Pricing varies depending on the formulation, concentration, and packaging. Ophthalmic ketorolac is typically sold in small sterile bottles, and the cost per milliliter is higher than oral forms due to specialized production requirements.
Acular LS is a lower‑strength formulation designed for reduced irritation, while Acuvail is a preservative‑free version often priced higher due to its advanced formulation. More details are available on the Acular ketorolac page.
Overall, ophthalmic ketorolac is priced differently from tablets or injections because it serves a different clinical purpose and requires sterile, small‑batch manufacturing.
Toradol is the brand name for ketorolac, while ketorolac itself is the generic equivalent. The price difference between brand and generic versions can be substantial, especially for injections and ophthalmic formulations. Generic ketorolac is significantly cheaper because it does not carry brand‑level marketing or development costs.
Despite the lower price, generic ketorolac contains the same active ingredient and must meet identical regulatory standards for quality, purity, and efficacy. For most patients, generic ketorolac provides the same therapeutic effect at a fraction of the cost.
Brand‑name Toradol may still be used in certain clinical settings due to institutional purchasing agreements or brand familiarity, but for retail consumers, generic ketorolac is almost always the more economical choice.
Ketorolac pricing varies significantly across global regions due to differences in healthcare systems, insurance coverage, regulatory frameworks, and pharmacy markups. In the United States, ketorolac injection and ophthalmic formulations tend to be more expensive due to higher healthcare costs and insurance‑based pricing models. Generic ketorolac tablets are more affordable but still vary widely by pharmacy.
In Canada, prices are generally lower due to government‑regulated drug costs, though availability of certain formulations may be more limited. Europe typically offers moderate pricing, with strong generic competition reducing the cost of oral ketorolac. Hospital‑only formulations such as injections may still be priced higher depending on the country.
In Asia, pricing varies dramatically by country. Some regions offer very low prices for generic ketorolac, while others have higher costs due to importation or limited local manufacturing.
Overall, ketorolac pricing reflects regional healthcare structures, regulatory environments, and market competition.
| Form | Dosage | Price (Range) | Use Setting |
|---|---|---|---|
| Injection | 15 mg | varies by region | Hospital / Clinic |
| Injection | 30 mg | varies by region | Hospital / Clinic |
| Injection | 60 mg | varies by region | Hospital / Clinic |
Ketorolac injections are the most expensive form due to sterile manufacturing, clinical‑grade packaging, and hospital‑level distribution. Prices vary by dosage, with 30 mg and 60 mg vials typically costing more because they are used in acute, high‑intensity pain scenarios. Regional pricing, pharmacy markup, and insurance coverage also influence the final cost.
| Form | Dosage | Price (Range) | Price per Tablet |
|---|---|---|---|
| Tablets | 10 mg | varies by region | varies by region |
Ketorolac tablets are the most affordable form of the medication. The standard 10 mg dosage is widely available in generic versions, making pricing highly competitive. Cost per tablet is low because oral formulations require simpler production and do not involve sterile manufacturing. Tablets are often used as continuation therapy after injections, further reducing overall treatment cost.
| Form | Price | Notes |
|---|---|---|
| Nasal spray | varies by region | Fast onset |
Ketorolac nasal spray is a rare formulation and is typically priced higher than tablets due to its specialized delivery system. It offers rapid absorption without injection, making it useful for patients who need fast relief but prefer a non‑invasive option. Limited availability and advanced manufacturing contribute to its higher cost.
| Form | Concentration | Price | Notes |
|---|---|---|---|
| Acular | 0.5% | varies by region | Standard |
| Acular LS | 0.4% | varies by region | Milder |
| Acuvail | 0.45% | varies by region | Preservative‑free |
Ophthalmic ketorolac is priced differently from tablets or injections because it requires sterile eye‑drop manufacturing, specialized packaging, and smaller production volumes. Variants like Acular LS and Acuvail differ in concentration and preservative content, which also affects pricing. Preservative‑free formulations are typically the most expensive.
| Type | Price | Comment |
|---|---|---|
| Toradol (brand) | Higher | Brand‑name product |
| Ketorolac (generic) | Lower | Equivalent formulation |
Brand‑name Toradol is consistently more expensive due to marketing, distribution, and brand recognition. Generic ketorolac contains the same active ingredient and must meet identical regulatory standards, making it a more economical option. The price gap is most noticeable in injections and ophthalmic formulations.
Ketorolac can be relatively expensive compared with other NSAIDs due to several factors. Injectable ketorolac requires sterile manufacturing, specialized packaging, and clinical‑grade distribution, all of which increase production costs. Because injections are used in hospitals, surgical centers, and emergency departments, pricing often reflects institutional procurement models rather than retail pharmacy pricing.
Ketorolac’s high potency also contributes to its cost. As one of the strongest non‑opioid analgesics, it is used in acute care settings where rapid, reliable pain control is essential. This clinical value increases demand for injectable and ophthalmic forms, which tend to be priced higher.
Brand‑name Toradol is more expensive than generic ketorolac due to branding, marketing, and distribution costs. In contrast, generic versions are widely available and significantly cheaper, especially for tablets.
Overall, ketorolac’s price reflects its potency, clinical utility, and the complexity of manufacturing certain formulations.
Comparing ketorolac prices effectively requires looking beyond the total cost of a package. The most important metric is the price per dose — for example, the cost per 10 mg tablet or per 30 mg injection. This allows accurate comparison across pharmacies, regions, and manufacturers.
For injectable ketorolac, price per milliliter is a useful metric because vials vary in size and concentration. A 30 mg/mL vial may appear more expensive than a 15 mg vial, but the cost per milligram may be lower. For ophthalmic forms like Acular, price per milliliter is also the most accurate comparison method.
For tablets, price per tablet is the simplest and most reliable metric. Generic ketorolac tablets typically offer the lowest cost per dose, while brand‑name Toradol tablets are priced higher.
Evaluating price per dose, per milliliter, or per tablet ensures a clear, accurate comparison across all ketorolac formulations.